Updated Jul 16, 2026
SCANGOS GEORGE A has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-23 | A | AGILENT TECHNOLOGIES, INC. | A — Grant or award | 1.1K | $111.75 | $118K |
| 2026-03-23 | A | AGILENT TECHNOLOGIES, INC. | A — Grant or award | 2.2K | $111.75 | $241K |
| 2024-10-24 | VIR | Vir Biotechnology, Inc. | J — Other acquisition / disposition | 598.3K | $0.00 | |
| 2024-10-24 | VIR | Vir Biotechnology, Inc. | J — Other acquisition / disposition | 598.3K | $0.00 | |
| 2024-10-24 | VIR | Vir Biotechnology, Inc. | J — Other acquisition / disposition | 598.3K | $0.00 | |
| 2024-10-24 | VIR | Vir Biotechnology, Inc. | J — Other acquisition / disposition | 598.3K | $0.00 |
SCANGOS GEORGE A is a corporate insider — currently tracked as Director of Voyager Therapeutics, Inc. (VYGR). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SCANGOS GEORGE A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.